Results
1 -
10 of
30Acetylcholinesterase inhibition ameliorates deficits in motivational drive, Behavioral and Brain Functions FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein, Journal of Molecular Neuroscience The alpha-synuclein 5u2032untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen, Journal of Neural Transmission Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze, Psychopharmacology Induction, Secretion, and Pharmacological Regulation of ??-App in Animal Model Systems, Progress in Alzheimer?s and Parkinson?s Diseases Phenserine: A Selective, Long-Acting and Brain-Directed Acetylcholinesterase Inhibitor Affecting Cognition and ??-APP Processing, Alzheimer Disease Phenserine Regulates Translation of ???Amyloid Precursor Protein Message, Mapping the Progress of Alzheimer?s and Parkinson?s Disease Dissociation Between the Potent ??-Amyloid Protein Pathway Inhibition and Cholinergic Actions of the Alzheimer Drug Candidates Phenserine and Cymserine, Advances in Alzheimer?s and Parkinson?s Disease Optimizing Drugs for Brain Action, Blood?Brain Barrier